RECURRENT MALIGNANT GLIOMA
Clinical trials for RECURRENT MALIGNANT GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MALIGNANT GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT MALIGNANT GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First-in-Human trial tests re-engineered immune cells to fight aggressive brain cancer
Disease control Recruiting nowThis early-stage study is testing a new type of personalized cell therapy for adults with aggressive brain tumors that have returned after prior treatment. Doctors take a patient's own immune cells, modify them in a lab to better target the cancer, and then infuse them back into …
Matched conditions: RECURRENT MALIGNANT GLIOMA
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 23:11 UTC
-
Targeted radiation attack on tough brain tumors in kids
Disease control Recruiting nowThis study is testing a drug called Lutathera in children and young adults (ages 4 to 39) with aggressive brain or spinal cord tumors that have come back or gotten worse after standard treatments. Lutathera is a targeted radiation therapy that seeks out and attaches to specific m…
Matched conditions: RECURRENT MALIGNANT GLIOMA
Phase: PHASE1, PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists hijack cold virus to target and attack deadly brain tumors
Disease control Recruiting nowThis early-stage trial is testing a new treatment for aggressive brain cancers that have returned. Doctors are using stem cells to carry a specially engineered cold virus directly to the tumor. The goal is to see if the virus can safely infect and kill the cancer cells while spar…
Matched conditions: RECURRENT MALIGNANT GLIOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC